Peptide Comparison
GHRH (1-29)vsCJC-1295 (No DAC)
The shortest synthetic growth hormone-releasing peptide that tells your body to build taller and stronger.
A modified growth hormone-releasing hormone that boosts your body's natural GH pulses for better recovery, deeper sleep, and improved body composition.
At a Glance
Quick
comparison
Dose Range
GHRH (1-29)
100–300 mcg
CJC-1295 (No DAC)
100–300 mcg
Frequency
GHRH (1-29)
Once daily
CJC-1295 (No DAC)
Once daily
Administration
GHRH (1-29)
Subcutaneous injection
CJC-1295 (No DAC)
Subcutaneous injection
Cycle Length
GHRH (1-29)
8-12 weeks
CJC-1295 (No DAC)
8-12 weeks
Onset Speed
GHRH (1-29)
Moderate (1-2 weeks)
CJC-1295 (No DAC)
Moderate (1-2 weeks)
Evidence Level
GHRH (1-29)
Strong human trials (Phase 3 or FDA approved)
CJC-1295 (No DAC)
Moderate human trials (Phase 1-2)
Efficacy
Benefit
ratings
Growth and Development
Body Composition
Performance and Recovery
GH Stimulation
Sleep Quality
Recovery Support
Technical Data
Compound
specifications
GHRH (1-29)
Molecular Formula
C149H246N44O42S
Molecular Weight
3357.9 g/mol
Half-Life
~10-20 minutes
Bioavailability
Subcutaneous: moderate; Intranasal: 3-5%
CAS Number
86168-78-7
CJC-1295 (No DAC)
Molecular Formula
C152H252N44O42
Molecular Weight
3367.9 g/mol
Half-Life
30 minutes to 2 hours
Bioavailability
~100% (subcutaneous)
CAS Number
863288-34-0
Protocols
Dosing
tiers
GHRH (1-29)
CJC-1295 (No DAC)
Applications
Best
suited for
GHRH (1-29)
Helping Kids Catch Up in Height
Children diagnosed with growth hormone deficiency struggle to reach normal heights. GHRH (1-29) works by sending a signal to the pituitary gland that says 'make more growth hormone.' Studies show children getting daily 30 mcg/kg doses at bedtime experienced sustained improvements in height velocity over 12+ months. It's gentle and lets the body do the work naturally.
Testing for Growth Problems
Doctors need a safe, accurate way to figure out if someone has a growth hormone deficiency. Giving a small dose of GHRH (1-29) and measuring the growth hormone response is fast and specific. It's like asking your pituitary gland 'can you produce growth hormone?' and listening to the answer.
Natural Optimization for Adults
Some adults have lower-than-optimal growth hormone levels as they age. GHRH (1-29) stimulates the body's own hormone factories rather than replacing hormones artificially. This approach keeps your body's natural feedback loops working properly.
CJC-1295 (No DAC)
Natural Growth Hormone Optimization
Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses.
Workout Recovery and Muscle Building
Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time.
Sleep Quality Enhancement
Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking.
Anti-Aging and Vitality
As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being.
Synergistic Peptide Stacking
Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone.
Safety Profile
Side
effects
GHRH (1-29)
Common
- Facial flushing
- Injection site discomfort
- Mild dizziness
Uncommon
- Nausea
- Headache
- Local allergic reaction
Serious
- Cardiovascular complications
CJC-1295 (No DAC)
Common
- Injection site reactions
- Flushing or warmth
- Water retention
- Increased appetite
Uncommon
- Tingling or numbness
- Headache
Serious
- Allergic reaction
Research Status
Safety
& evidence
GHRH (1-29)
Evidence Level
Strong human trials (Phase 3 or FDA approved)
FDA Status
FDA approved for this use
Safety Overview
GHRH (1-29) has been studied extensively in both children and adults. It works by mimicking a natural hormone your body already produces, making it relatively gentle. Side effects are typically mild and temporary, mainly limited to facial flushing and minor injection site reactions. Long-term studies show it's well-tolerated when used as directed.
Contraindications
- xActive malignancy or recent cancer diagnosis
- xAcute critical illness or severe infection
- xKnown hypersensitivity to sermorelin or any component
CJC-1295 (No DAC)
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
CJC-1295 without DAC has been studied in Phase 1-2 human clinical trials with a favorable safety profile. The most common side effects are mild and include injection site reactions and temporary flushing. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms.
Contraindications
- xActive cancer or history of cancer
- xPregnancy or breastfeeding
- xPituitary tumors or disorders
- xHypersensitivity to GHRH analogs
- xDiabetic retinopathy
Decision Guide
Which is
right for you?
Choose GHRH (1-29) if...
- Children with growth hormone deficiency who need to catch up in height
- Adults seeking to optimize natural growth hormone levels
- People being tested for growth hormone deficiency
Choose CJC-1295 (No DAC) if...
- Increasing natural growth hormone levels
- Building lean muscle mass
- Improving sleep quality
- Enhancing workout recovery